Literature DB >> 17122580

Influence of mannitol and furosemide, alone and in combination, on brain water content after fluid percussion injury.

Michael M Todd1, Johann Cutkomp, Johnny E Brian.   

Abstract

BACKGROUND: Furosemide and mannitol are used to reduce intracranial pressure, but the impact of furosemide on edema of injured brain is unclear. The authors examined the effects of furosemide and mannitol, alone and in combination, on brain water content in brain-injured rats.
METHODS: Anesthetized rats were subjected to a 2.2-atm left hemispheric fluid percussion injury. Two and three-quarters hours later, animals received 0.5, 1, 4, or 8 g/kg mannitol; 8 mg/kg furosemide; a combination of 4 g/kg mannitol plus 4 mg/kg furosemide; or 8 g/kg mannitol plus 8 mg/kg furosemide. One hour later (4 h after injury), plasma osmolality was measured, and hemispheric water content was determined by drying. Other animals were subjected to injury without drug treatment (impact only) or did not undergo injury (control). Pairwise group comparisons regarding the effects of mannitol and furosemide were restricted to only four groups: impact only, 8 g/kg mannitol, 8 mg/kg furosemide, and 8 g/kg mannitol plus 8 mg/kg furosemide.
RESULTS: The water content of both hemispheres in the impact-only group was greater than in the control group (left greater than right). Mannitol, 8 g/kg, increased osmolality from 306 +/- 4 to 351 +/- 6 mOsm/kg (mean +/- SD) and reduced water content in the left hemisphere from 80.06 +/- 0.84% (impact only) to 78.24 +/- 0.73%. Furosemide, 8 mg/kg, had no effect on osmolality or water content. Brain water in animals treated with 8 g/kg mannitol plus 8 mg/kg furosemide did not differ from that seen with 8 g/kg mannitol alone.
CONCLUSIONS: Mannitol increased plasma osmolality and reduced water content of the injured and contralateral hemispheres, whereas the authors observed no effect of furosemide when given either alone or in combination with mannitol.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17122580     DOI: 10.1097/00000542-200612000-00017

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  7 in total

Review 1.  Severe Cranioencephalic Trauma: Prehospital Care, Surgical Management and Multimodal Monitoring.

Authors:  Luis Rafael Moscote-Salazar; Andres M Rubiano; Hernando Raphael Alvis-Miranda; Willem Calderon-Miranda; Gabriel Alcala-Cerra; Marco Antonio Blancas Rivera; Amit Agrawal
Journal:  Bull Emerg Trauma       Date:  2016-01

Review 2.  Combination therapies for neurobehavioral and cognitive recovery after experimental traumatic brain injury: Is more better?

Authors:  Anthony E Kline; Jacob B Leary; Hannah L Radabaugh; Jeffrey P Cheng; Corina O Bondi
Journal:  Prog Neurobiol       Date:  2016-05-07       Impact factor: 11.685

Review 3.  The Medical Management of Cerebral Edema: Past, Present, and Future Therapies.

Authors:  Michael R Halstead; Romergryko G Geocadin
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

4.  Brain-Relaxing Effect of Different Diuretic Regimens in Supratentorial Tumor Surgery: A Comparative Study Guided by Optic Nerve Sheath Diameter.

Authors:  Mohamed Adel Aboelela; Alrefaey Kandeel Alrefaey
Journal:  Anesth Essays Res       Date:  2021-03-22

5.  The effect of mannitol on intraoperative brain relaxation in patients undergoing supratentorial tumor surgery: study protocol for a randomized controlled trial.

Authors:  Yuming Peng; Xiaoyuan Liu; Aidong Wang; Ruquan Han
Journal:  Trials       Date:  2014-05-10       Impact factor: 2.279

Review 6.  Principles of neuroanesthesia in aneurysmal subarachnoid hemorrhage.

Authors:  Sandeep Kundra; Vidhi Mahendru; Vishnu Gupta; Ashwani Kumar Choudhary
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2014-07

7.  The effect of mild decrement in plasma volume simulating short-duration spaceflight on intracranial pressure.

Authors:  Takuya Kurazumi; Yojiro Ogawa; Hiroshi Morisaki; Ken-Ichi Iwasaki
Journal:  NPJ Microgravity       Date:  2018-10-02       Impact factor: 4.415

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.